Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of an Oxymizer Versus Conventional Nasal Cannula on Endurance Time in Patients With Chronic Obstructive Pulmonary Disease IV (COPD) or Interstitial Lung Disease (ILD)

NCT01713413 is registered in ClinicalTrials.gov with Schön Klinik Berchtesgadener Land as lead sponsor.

NCT NCT01713413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01713413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of an Oxymizer Versus Conventional Nasal Cannula on Endurance Time in Patients With Chronic Obstructive Pulmonary Disease IV (COPD) or Interstitial Lung Disease (ILD)
Lead sponsor
Schön Klinik Berchtesgadener Land
Phase
Not applicable
Overall status
Completed
Start date
February 29, 2012
Completion date
March 31, 2014
Enrollment
67 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd, interstitial lung disease